DARE (Dare Bioscience, Inc.) Projected Price to Earnings

Corporate company logo of Daré Bioscience (DARE)

Sabrina Johnson's team is successfully implementing AI platforms to drive innovation in women's health at Dare Bioscience, Inc. (DARE). The company's forward P/E dynamics reflect the current business valuation, with the latest value recorded as 0.00. However, the issuer's overall stability remains low due to its reliance on grants and the fact that most drugs under development are still in clinical trial stages.

Projected Price to Earnings Ratio: Daré Bioscience (DARE) for 07/04/2022 - 11/12/2026

Summary analytical data breakdowns for Daré Bioscience, Inc. (DARE)

- current price and projected stock value:
Stock Quotes Daré Bioscience|DARE - Fair Value Consensus
- business market valuation indicators:
Market Valuation Dare Bioscience, Inc.|DARE - Real Price to Acquire Entire Company
- issuer book value statistics:
Net Assets per Single Share Daré Bioscience|DARE - Total Stockholders' Equity|Market Value to Book Value Ratio darebioscience.com|DARE - Cumulative Company Assets
- issuer credit burden and liquidity indicators:
Total Debt to Capital Dare Bioscience, Inc.|DARE - Long-Term Liabilities to Capital|Short-Term Debt to Equity Dare Bioscience, Inc.|DARE - Company Aggregate Debt|Debts to Book Capitalization Dare Bioscience, Inc.|DARE - Company Long-Term Indebtedness|Company Short-Term Debts Daré Bioscience|Quick Liquidity darebioscience.com
- company profitability and valuation multiples indicators:
DARE - Final Profit|Projected Future Earnings Dare Bioscience, Inc.|DARE - Market Cap to Earnings|Projected Price to Earnings Dare Bioscience Inc.|DARE - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Dare Bioscience, Inc.|DARE - Profit before payment of interest, taxes and amortization|Net earnings per share (EPS TTM) Daré Bioscience|DARE - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months darebioscience.com|DARE - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Dare Bioscience, Inc.
Summary company analytics:Daré Bioscience
Brand item of Dare Bioscience, Inc.

Dare Bioscience, Inc. (DARE) operates within a specific women's health cycle where business value depends on the success of clinical trials and partner payments. This forward P/E ratio for Dare Bioscience, Inc. (DARE) reflects the market discounting of expected cash flows by comparing current quotes with future net income, allowing investors to assess the premium paid for the issuer's future growth.

Who Dare Bioscience, Inc. competes with

Projected Price to Earnings OGN (Organon)|TXMD (therapeuticsmd.com) - Future Price to Earnings Multiple|Palatin - Projected Price to Earnings